The TaqI gene polymorphisms of VDR and the circulating 1,25- dihydroxyvitamin D levels confer the risk for the keloid scarring in Chinese cohorts

Cellular Physiology and Biochemistry

Volumn 32, Issue 1, 2013, Pages 39-45

  Yu, Dongmei ^a   Shang, Yong ^a   Luo, Sai ^a   Hao, Lijun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

25 Hydroxyvitamin D levels; Keloid scar; Risk; Vitamin D receptor

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR; 25 HYDROXYVITAMIN D;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KELOID; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK; STRATIFICATION; TAQI GENE; COHORT ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; INCIDENCE; RECEPTOR GENE; REFERENCE VALUE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D RECEPTOR GENE;

ADULT; ALLELES; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENOTYPE; HUMANS; KELOID; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK FACTORS; ROC CURVE; SEX FACTORS; TAQ POLYMERASE; VITAMIN D; YOUNG ADULT;

EID: 84880183376     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000350121     Document Type: Article

References (24)

1. Lee JY, Yang CC, Chao SC, Wong TW: Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 2004;26:379-384.
2. Emami A, Halim AS, Salahshourifar I, Yussof SJ, Khoo TL, Kannan TP: Association of TGFbeta1 and SMAD4 variants in the etiology of keloid scar in the Malay population. Arch Dermatol Res 2012;304:541-547.
3. Tsao SS, Dover JS, Arndt KA, Kaminer MS: Scar management: keloid, hypertrophic, atrophic, and acne scars. Semin Cutan Med Surg 2002;21:46-75.
4. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G: Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145:105-113.
5. Rossiello L, D'Andrea F, Grella R, Signoriello G, Abbondanza C, De Rosa C, Prudente M, Morlando M, Rossiello R: Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues. Wound Repair Regen 2009;17:750-757.
6. Halim AS, Emami A, Salahshourifar I, Kannan TP: Keloid scarring: understanding the genetic basis, advances, and prospects. Arch Plast Surg 2012;39:184-189.
7. Muller DN, Kleinewietfeld M, Kvakan H: Vitamin D review. J Renin Angiotensin Aldosterone Syst 2011;12:125-128.
8. Zhang GY, Cheng T, Luan Q, Liao T, Nie CL, Zheng X, Xie XG, Gao WY: Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol 2011;164:729-737.
9. Subramaniam N, Leong GM, Cock TA, Flanagan JL, Fong C, Eisman JA, Kouzmenko AP: Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements. J Biol Chem 2001;276:15741-15746.
10. Kato S, Yoko Y: [VDR function in skin]. Clin Calcium 2004;14:116-119.
11. Slattery ML: Vitamin D receptor gene (VDR) associations with cancer. Nutr Rev 2007;65:S102-104.
12. Christensen MH, Apalset EM, Nordbo Y, Varhaug JE, Mellgren G, Lien EA: 1,25-dihydroxyvitamin d and the vitamin d receptor gene polymorphism apa1 influence bone mineral density in primary hyperparathyroidism. PLoS One 2013;8:e56019.
13. Srinivasan M, Parwani AV, Hershberger PA, Lenzner DE, Weissfeld JL: Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol 2011;123:30-36.
14. Li Y, Spataro BC, Yang J, Dai C, Liu Y: 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int 2005;68:1500-1510.
15. Tan X, Li Y, Liu Y: Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2006;17:3382-3393.
16. Koleganova N, Piecha G, Ritz E, Gross ML: Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol Dial Transplant 2009;24:778-787.
17. Humbert PG, Dupond JL, Rochefort A, Vasselet R, Lucas A, Laurent R, Agache P: Localized scleroderma- response to 1,25-dihydroxyvitamin D3. Clin Exp Dermatol 1990;15:396-398.
18. Diao JS, Xia WS, Yi CG, Wang YM, Li B, Xia W, Liu B, Guo SZ, Sun XD: Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. Arch Dermatol Res 2011;303:573-580.
19. Gao Z, Wang Z, Shi Y, Lin Z, Jiang H, Hou T, Wang Q, Yuan X, Zhao Y, Wu H, Jin Y: Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA. Plast Reconstr Surg 2006;118:1328-1337.
20. Wang Z, Gao Z, Shi Y, Sun Y, Lin Z, Jiang H, Hou T, Wang Q, Yuan X, Zhu X, Wu H, Jin Y: Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007;60:1193-1199.
21. Kato S: The function of vitamin D receptor in vitamin D action. J Biochem 2000;127:717-722.
22. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR: Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001;177:145-159.
23. Thakkinstian A, D'Este C, Attia J: Haplotype analysis of VDR gene polymorphisms: a meta-analysis. Osteoporos Int 2004;15:729-734.
24. Bhanushali AA, Lajpal N, Kulkarni SS, Chavan SS, Bagadi SS, Das BR: Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels. Indian J Hum Genet 2009;15:108-113.